Ariston Holding N.V. (BIT:ARIS)

Achilles Therapeutics Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,650	2,633	3,092	2,379	1,987	1,664
Other Revenue	32.7	47.4	58.3	42.7	34.2	27.9
Revenue	2,683	2,680	3,150	2,422	2,022	1,692
Revenue Growth (YoY)	-7.48%	-14.92%	30.09%	19.79%	19.48%	-1.07%
Cost of Revenue	1,614	1,613	1,874	1,553	1,260	988.4
Gross Profit	1,068	1,067	1,276	868.9	761.2	703.5
Selling, General & Admin	695.4	744.1	761.2	520.8	465.9	430.1
Other Operating Expenses	32.1	75.7	99.8	61.4	43.2	44.3
Operating Expenses	868.1	959.5	992.4	672	584.9	552.1
Operating Income	200.3	107.8	283.9	196.9	176.3	151.4
Interest Expense	-38.3	-41.2	-35.8	-12.2	-9.1	-10.9
Interest & Investment Income	4.2	6.2	6.2	2.9	1.6	1.6
Currency Exchange Gain (Loss)	1.1	-5.5	1.5	-8.9	4.1	-3.5
Other Non Operating Income (Expenses)	-0.2	0.1	1.7	0.5	-0.1	-2.5
EBT Excluding Unusual Items	167.1	67.4	257.5	179.2	172.8	136.1
Merger & Restructuring Charges	-6.5	-7.4	0.6	-0.6	-1.6	-1.4
Gain (Loss) on Sale of Investments	-8.2	-4.6	-1.3	4.7	-1.9	-1.3
Gain (Loss) on Sale of Assets	-35.7	-35.7	-	-	-	-
Asset Writedown	-5.2	-5.1	-1.1	-3.8	-1.7	-0.2
Legal Settlements	-1.2	-0.9	-2.1	0.4	-2.2	-1.3
Pretax Income	110.3	13.7	253.6	179.9	165.4	131.9
Income Tax Expense	17	11.4	62.4	39.5	29.1	35.2
Earnings From Continuing Operations	93.3	2.3	191.2	140.4	136.3	96.7
Minority Interest in Earnings	-0.2	0.2	-	-0.1	0.2	-
Net Income	93.1	2.5	191.2	140.3	136.5	96.7
Net Income to Common	93.1	2.5	191.2	140.3	136.5	96.7
Net Income Growth	61.35%	-98.69%	36.28%	2.78%	41.16%	8.63%
Shares Outstanding (Basic)	369	370	371	330	293	28
Shares Outstanding (Diluted)	369	370	372	331	295	28
Shares Change (YoY)	-0.66%	-0.46%	12.37%	12.01%	940.64%	-
EPS (Basic)	0.25	0.01	0.52	0.43	0.47	3.41
EPS (Diluted)	0.25	0.01	0.51	0.42	0.46	3.41
EPS Growth	68.10%	-98.67%	21.43%	-8.70%	-86.49%	8.63%
Free Cash Flow	230.5	224.4	175.1	73.3	131.7	222.8
Free Cash Flow Per Share	0.63	0.61	0.47	0.22	0.45	7.85
Dividend Per Share	0.080	0.080	0.170	0.130	0.140	-
Dividend Growth	-52.94%	-52.94%	30.77%	-7.14%	-	-
Gross Margin	39.82%	39.82%	40.52%	35.88%	37.66%	41.58%
Operating Margin	7.47%	4.02%	9.01%	8.13%	8.72%	8.95%
Profit Margin	3.47%	0.09%	6.07%	5.79%	6.75%	5.71%
Free Cash Flow Margin	8.59%	8.37%	5.56%	3.03%	6.51%	13.17%
EBITDA	282.05	188	361	286.7	230.8	205.4
EBITDA Margin	10.51%	7.02%	11.46%	11.84%	11.42%	12.14%
D&A For EBITDA	81.75	80.2	77.1	89.8	54.5	54
EBIT	200.3	107.8	283.9	196.9	176.3	151.4
EBIT Margin	7.47%	4.02%	9.01%	8.13%	8.72%	8.95%
Effective Tax Rate	15.41%	83.21%	24.61%	21.96%	17.59%	26.69%
Revenue as Reported	2,683	2,680	3,150	2,422	2,022	-
Advertising Expenses	-	36.3	47.6	41.2	37.4	30.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.